Speakers will focus on clinical, cost and access topics that create value in oncology

Thought leaders from McKesson will play a major role in the upcoming 2022 Association for Value-Based Cancer Care (AVBCC) Summit, speaking on a wide range of topics that showcase their extensive knowledge of the changing healthcare landscape and oncology’s transformation to value-based care. The Summit, to be held Oct. 19-21, 2022, in New York City, is an invitational forum that provides invaluable access to more than 200 diverse experts representing every stakeholder of the cancer care ecosystem.

“Staying ahead of the rapidly evolving landscape is challenging, and events like this greatly help, bringing together some of the best practices and ideas we can share to improve practice sustainability, clinical research and cancer care,” said Lalan Wilfong, MD, vice president, Payer Relations & Practice Transformation, The US Oncology Network. “We are committed to being at the forefront of value-based care and are excited to have the opportunity to collaborate with other thought leaders at this important meeting.”

Summit participants will gain insights from a diverse range of practitioners, pharmacists, payers, policymakers and other key stakeholders who are nationally recognized in their fields. Attendees will learn strategies on how to stay competitive in the ever-changing field of oncology, explore cutting-edge methodologies enabling value-based care that can rapidly be implemented, and gain access to timely and accurate information from reliable sources to empower good decision-making. It facilitates achievable change by providing a forum for payers, providers and the entire oncology team to network and evaluate value in terms of quality, cost and impact on patient care and outcomes.

McKesson is represented at the Summit by several of its experts, speaking on a diverse array of topics including value-based agreements, oncology drug trends, pathways and decision support models. Summit sessions featuring affiliated speakers as panelists are:

• Headwinds and Tailwinds Ahead for Value-Based Agreements (Oct. 19, 8:30 a.m.-9:30 a.m.)
  • Lalan Wilfong, MD, vice president, Payer Relations & Practice Transformation, The US Oncology Network

• Succeeding in Value-Based Payment Arrangements: ASCO’s Patient Centered Cancer Care Certification Pilot (Oct. 19, 10:30 a.m.-11:30 a.m.)
  • Matthew Skelton, MD, oncologist and physician champion for value-based care, Blue Ridge Cancer Care, a practice in The US Oncology Network

• Legal and Regulatory Issues Surrounding Value-Based Agreements (Oct. 19, 2:15 p.m.-3:15 p.m.)
  • Ben Jones, vice president, Government Relations & Public Policy, The US Oncology Network

• Lessons Learned from OCM That Should Be Incorporated into EOM and Future Cancer Care Models (Oct. 20, 9:45 a.m.-10:45 a.m.)
  • Marcus Neubauer, MD, chief medical officer, The US Oncology Network

• How Long is the Last Mile? Real-World Evidence’s Vast Potential and Challenges in Oncology (Oct. 20, 3:15 p.m.-4 p.m.)
  • Viraj Narayanan, chief commercial officer, Ontada

• Utilization of Pathways in Precision Medicine to Impact Patient Care (Oct. 21, 8 a.m.-9 a.m.)
  • Ira Zackon, MD, senior medical director, Ontada

• The Impact Pathways Have on Outcomes and Value (Oct. 21, 10 a.m.-11 a.m.)
  • Lalan Wilfong, MD, vice president, Payer Relations & Practice Transformation, The US Oncology Network, and Marcus Neubauer, MD, chief medical officer, The US Oncology Network

• Oncology Drug Supply Channels and the Move to Smart Networks and Supporting Value-Based Agreements (Oct. 21, 10 a.m.-11 a.m.)
  • Heather Morel, PhD, president, Provider Solutions, McKesson

• Practice Transformation Through Value-Based Analytics (Oct. 21, 11 a.m.-12 p.m.)
  • Lalan Wilfong, MD, vice president, Payer Relations & Practice Transformation, The US Oncology Network

• Payer and Provider Innovative Value-Based Agreement (Oct. 21, 2 p.m.-2:45 p.m.)
  • Rhonda Henschel, senior director, Payer Solutions, The US Oncology Network, and Jay Scott, director, Managed Care, Minnesota Oncology, a practice in The US Oncology Network

• AI and ML Decision Support Models (Oct. 21, 2 p.m.-2:45 p.m.)
  • Ira Zackon, MD, senior medical director, Ontada

The live event is invitation-only, limiting the number of guests to adhere to COVID-19 safety guidelines; however, there will be a virtual simulcast of the entire Summit for those who cannot attend in person.

About McKesson Corporation

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Our Stories.

About The US Oncology Network

Every day, The US Oncology Network (The Network) helps approximately 1,400 independent physicians deliver value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network provides practices with access to coordinated resources, best business practices, and the experience, infrastructure and support of McKesson Corporation. This collaboration allows the providers in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. The Network is committed to the success of independent practices, everywhere.

About Ontada

Ontada® is an oncology real-world data and evidence, clinical education and provider technology business dedicated to transforming the fight against cancer. Part of McKesson Corporation, we support science through our data, technology and channels, which accelerate innovation for life science companies, support the education of community oncology providers and advance patient care. Together with our partners, we improve the lives of cancer patients. For more information, visit ontada.com or follow @OntadaOncology.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221018005152/en/